electroCore, Inc. ECOR Bioelectronic Innovations — Operating Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by electroCore, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: electroCore, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about electroCore, Inc.'s bioelectronic innovations — operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is electroCore, Inc.'s bioelectronic innovations — operating expenses?
- electroCore, Inc. (ECOR) reported bioelectronic innovations — operating expenses of $13.68M in Q1 2026.
- How has electroCore, Inc.'s bioelectronic innovations — operating expenses changed year-over-year?
- electroCore, Inc.'s bioelectronic innovations — operating expenses increased by 43.6% year-over-year, from $9.53M to $13.68M.
- What does bioelectronic innovations — operating expenses mean?
- Operating expenses represent the total costs incurred to run the day-to-day operations of the bioelectronic innovations segment, including research, marketing, and administrative overhead. This metric is essential for evaluating the overall cost structure and burn rate of the business unit.